JP2000516924A - ５ｈｔ▲下２ｃ▼アンタゴニストおよびｄ▲下２▼アンタゴニストを含む医薬組成物 - Google Patents

５ｈｔ▲下２ｃ▼アンタゴニストおよびｄ▲下２▼アンタゴニストを含む医薬組成物

Info

Publication number
JP2000516924A
JP2000516924A JP10508522A JP50852298A JP2000516924A JP 2000516924 A JP2000516924 A JP 2000516924A JP 10508522 A JP10508522 A JP 10508522A JP 50852298 A JP50852298 A JP 50852298A JP 2000516924 A JP2000516924 A JP 2000516924A
Authority
JP
Japan
Prior art keywords
antagonist
compound
pharmaceutically acceptable
acceptable salt
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10508522A
Other languages
English (en)
Japanese (ja)
Inventor
ブラックバーン，トーマス・ポール
Original Assignee
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー filed Critical スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー
Publication of JP2000516924A publication Critical patent/JP2000516924A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP10508522A 1996-07-26 1997-07-22 ５ｈｔ▲下２ｃ▼アンタゴニストおよびｄ▲下２▼アンタゴニストを含む医薬組成物 Pending JP2000516924A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9615767.2 1996-07-26
GBGB9615767.2A GB9615767D0 (en) 1996-07-26 1996-07-26 Novel treatment
PCT/EP1997/004159 WO1998004289A2 (en) 1996-07-26 1997-07-22 Pharmaceutical composition containing a 5ht2c antagonist and a d2 antagonist

Publications (1)

Publication Number Publication Date
JP2000516924A true JP2000516924A (ja) 2000-12-19

Family

ID=10797573

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10508522A Pending JP2000516924A (ja) 1996-07-26 1997-07-22 ５ｈｔ▲下２ｃ▼アンタゴニストおよびｄ▲下２▼アンタゴニストを含む医薬組成物

Country Status (19)

Country Link
EP (1) EP0936924A2 (hu)
JP (1) JP2000516924A (hu)
KR (1) KR20000029564A (hu)
CN (1) CN1230894A (hu)
AR (1) AR008083A1 (hu)
AU (1) AU725817B2 (hu)
BR (1) BR9710568A (hu)
CA (1) CA2261813A1 (hu)
CO (1) CO5031292A1 (hu)
CZ (1) CZ23799A3 (hu)
GB (1) GB9615767D0 (hu)
HU (1) HUP9903619A3 (hu)
IL (1) IL128219A0 (hu)
NO (1) NO990322L (hu)
NZ (1) NZ333813A (hu)
PL (1) PL331426A1 (hu)
TR (1) TR199900140T2 (hu)
WO (1) WO1998004289A2 (hu)
ZA (1) ZA976593B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9612883D0 (en) * 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
WO2000030649A1 (en) * 1998-11-23 2000-06-02 Sepracor Inc. Pharmaceutical compositions containing olanzapine-n-oxide
US6348455B1 (en) 1998-11-23 2002-02-19 Sepracor Inc. Desmetylolanzapine compositions and methods
JP2002530339A (ja) 1998-11-23 2002-09-17 セプラコール， インク． ２−ヒドロキシメチルオランザピン組成物及び方法
AU3757500A (en) 1999-03-18 2000-10-04 Childrens Hospital Research Foundation A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications
WO2000071106A2 (en) * 1999-05-19 2000-11-30 Astrazeneca Ab Method of treating weight gain
WO2005013969A1 (en) * 2003-07-15 2005-02-17 Janssen Pharmaceutica N.V. Antipsychotic agent with socializing properties

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500998D0 (sv) * 1995-03-19 1995-03-19 Haakan Wilhelm Wikstroem New sulfone ester analogues of iso-clozapine and related structures: atypical neuroleptics

Also Published As

Publication number Publication date
ZA976593B (en) 1999-01-25
GB9615767D0 (en) 1996-09-04
AU4297297A (en) 1998-02-20
WO1998004289A3 (en) 1998-03-19
CA2261813A1 (en) 1998-02-05
BR9710568A (pt) 1999-08-17
NZ333813A (en) 2000-07-28
KR20000029564A (ko) 2000-05-25
NO990322L (no) 1999-03-24
AU725817B2 (en) 2000-10-19
IL128219A0 (en) 1999-11-30
HUP9903619A2 (hu) 2000-10-28
PL331426A1 (en) 1999-07-19
CZ23799A3 (cs) 1999-06-16
WO1998004289A2 (en) 1998-02-05
CO5031292A1 (es) 2001-04-27
NO990322D0 (no) 1999-01-25
AR008083A1 (es) 1999-12-09
EP0936924A2 (en) 1999-08-25
HUP9903619A3 (en) 2001-03-28
CN1230894A (zh) 1999-10-06
TR199900140T2 (xx) 1999-03-22

Similar Documents

Publication Publication Date Title
DE60122767T2 (de) Indoly-lsulphonyl-verbindungen zur behandlung von störungen des zns
JP2000512646A (ja) ５ｈｔ７受容体アンタゴニストとしてのスルホンアミド誘導体
JP3834098B2 (ja) ベンゾニトリル類およびベンゾフルオリド類
JPH09501171A (ja) ５ｈｔ１ｄ受容体アンタゴニストとしてのアミド誘導体
JPH09502177A (ja) ５ｈｔ１ｄレセプター拮抗薬用インドールおよびインドリン誘導体
JP2005525332A (ja) ５−ｈｔ６受容体アフィニティーを有するスルホニル化合物
JP4327091B2 (ja) ２，７−置換インドール及び５−ｈｔ６モジュレーターとしてのその使用
JP3157179B2 (ja) ３−アリールカルボニル−１−アミノアルキル−１ｈ−インドール含有抗緑内障組成物
WO1996011930A1 (en) Cns-active pyridinylurea derivatives
WO1997008167A1 (en) 5ht2c and 5ht2b antagonists
US6391891B1 (en) Bicyclic compounds as ligands for 5-HT1 receptors
JPH08502273A (ja) ５−ｈｔ▲下４▼レセプターアンタゴニスト用複素環式エステルまたはアミド
US6313145B1 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists
JP2000516924A (ja) ５ｈｔ▲下２ｃ▼アンタゴニストおよびｄ▲下２▼アンタゴニストを含む医薬組成物
JP2000512306A (ja) ５―ｈｔ―２ｃ受容体アンタゴニストとして有用なインドリン誘導体
CN105026399A (zh) 作为钾离子通道抑制剂的吡咯并三嗪类化合物
JPH09512025A (ja) ５ｈｔ▲下２ｃ▼および５ｈｔ▲下２ｂ▼アンタゴニストとしての三環式誘導体
JP2003513097A (ja) Ｃｎｓ障害治療用のイソキノリンおよびキナゾリン誘導体
EP0984956A1 (en) Indoline derivatives as 5ht2c receptor antagonists
JP2000507254A (ja) アザスピロ誘導体
EP0743946A1 (en) 5ht2b receptor antagonists condensed indoles
JPH11514661A (ja) ５ｍｔレセプターアンタゴニストとしてのスピロピペリジン誘導体
KR100486795B1 (ko) 5-ht-2c수용체길항제로유용한인돌린유도체
EP1226120B1 (en) Benz[f]indoles for use in the treatment of 5ht receptor related disorders